title: Is terbinafine responsible for eliciting positive patch tests performed with Lamisil tablets?
authors.affiliation: Dermatology Department, Fournier Hospital, Nancy, France.
authors.forename: A
authors.initials: A
authors.lastname: Barbaud
authors.forename: S
authors.initials: S
authors.lastname: Reichert-Penetrat
authors.forename: F
authors.initials: F
authors.lastname: Granel
authors.forename: M N
authors.initials: MN
authors.lastname: Kolopp-Sarda
authors.forename: J L
authors.initials: JL
authors.lastname: Schmutz
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009281:Naphthalenes / Q000008:administration & dosage / Q000009:adverse effects*; D010328:Patch Tests; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D013607:Tablets / Q000009:adverse effects*; D000077291:Terbinafine
chemical_list: D000935:Antifungal Agents; D009281:Naphthalenes; D013607:Tablets; D000077291:Terbinafine